India launches first indigenous CRISPR based gene therapy for Sickle Cell Disease | Current Affairs | Vision IAS
News Today Logo

    India launches first indigenous CRISPR based gene therapy for Sickle Cell Disease

    Posted 20 Nov 2025

    2 min read

    Article Summary

    Article Summary

    India introduces its first indigenous CRISPR-based gene therapy, BIRSA 101, developed by CSIR–IGIB, to treat Sickle Cell Disease, notably affecting India's tribal populations, utilizing innovative genome-editing techniques.

    The Gene Therapy, named BIRSA 101 is dedicated to Bhagwan Birsa Munda, a great tribal freedom fighter.

    • It is developed by CSIR–Institute of Genomics and Integrative Biology (IGIB)

    About Gene Therapy

    • Gene therapy is a technique that uses a gene(s) to treat, prevent or cure a disease or medical disorder.
    • Working Mechanism: Add new copies of a gene that is broken, or replace a defective or missing gene in a patient’s cells with a healthy version (therapeutic gene) of that gene.

    About CRISPR 

    • CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats
    • It is a genome-editing tool that enables scientists to cut and modify DNA sequences precisely.
    • It involves two key molecules
      • Guide RNA: Designed to find and bind to specific parts of the target genome.
      • Cas9 (CRISPR-associated protein 9): It acts as molecular scissors that can cut two strands of DNA.

    About Sickle-cell disease (SCD)

    • SCD is a genetic disorder that affects haemoglobin, the molecule in red blood cells responsible for carrying oxygen. 
    • The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow. 
    • It particularly affects India's tribal population. (1 in 86 births among STs have SCD)

    Related News

    enFnCas9

    • An agreement was exchanged between CSIR-IGIB and the Serum Institute of India Pvt. Ltd., to translate enFnCas9 into scalable, affordable therapies for genetic disorders.
    • enFnCas9 (Francisella novicida Cas9 (FnCas9) protein) is an engineered high-fidelity CRISPR-Cas9 platform, developed by IGIB. 
    • Tags :
    • CRISPR
    • Gene Editing
    • BIRSA 101
    • Sickle-cell disease
    Watch News Today
    Subscribe for Premium Features